title: Optimising management in Turner syndrome: from infancy to adult transfer.
abstract: Turner syndrome can be defined as loss or abnormality of the second X chromosome in at least one cell line in a phenotypic female. The condition occurs in approximately 1 in every 2000 live female births,(1) so that in the UK the prevalence for any year of life is in the region of 200 girls. The condition is much more common in utero, it being estimated that 1-2% of all conceptuses are affected, of whom only 1% will survive to term.
authors.affiliation: University of Glasgow, Department of Child Health, Royal Hospital for Sick Children, Glasgow, UK. mdcd1t@clinmed.gla.ac.uk
authors.forename: M D C
authors.initials: MD
authors.lastname: Donaldson
authors.forename: E J
authors.initials: EJ
authors.lastname: Gault
authors.forename: K W
authors.initials: KW
authors.lastname: Tan
authors.forename: D B
authors.initials: DB
authors.lastname: Dunger
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004967:Estrogens / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D005838:Genotype; D013006:Growth Hormone / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D010641:Phenotype; D014424:Turner Syndrome / Q000150:complications / Q000235:genetics / Q000628:therapy*
chemical_list: D004967:Estrogens; D004997:Ethinyl Estradiol; D013006:Growth Hormone